logo
Hepatitis C therapy in non-genotype 1 patients: the near future
Glycyrrhizin in patients who failed previous interferon alpha-based therapies: biochemical and histological effects after 52 weeks
High-dose silibinin rescue treatment for HCV-infected patients showing suboptimal virologic response to standard combination therapy
Hepatitis C virus-specific immune responses in noninjecting drug users
HCV burden of infection in Egypt: results from a nationwide survey
Liver kidney microsomal type 1 antibodies reduce the CYP2D6 activity in patients with chronic hepatitis C virus infection
Immigrant patients with chronic hepatitis C and advanced fibrosis have a higher risk of hepatocellular carcinoma
A pilot randomized controlled trial of dual-plasmid HBV DNA vaccine mediated by in vivo electroporation in chronic hepatitis B patients under lamivudine chemotherapy
Hepatocellular carcinoma screening practices and impact on survival among hepatitis B-infected Asian Americans